# $SHIP Social Sentiment & Intelligence — 2026-08-10 12:50 UTC

> **Asset:** $SHIP  
> **Momentum Status:** Stable  
> **Timestamp:** 2026-08-10 12:50 UTC (2026-08-10T12:50:00Z)  
> **Canonical URL:** https://cryptitalk.com/2026-08-10-12-50/crypto/SHIP  
> **Overview Brief:** https://cryptitalk.com/2026-08-10-12-50/crypto.md  

---

## 10-Minute Social Metrics
- **Posts Analyzed:** 1
- **Total Impressions:** 0
- **Likes:** 0
- **Retweets:** 0
- **Comments:** 0

---


## Momentum & Sentiment Analysis
Total Engagement - Comments: 0, Retweets: 0, Likes: 0, Impressions: 0


---

## Cited Community Posts & Evidence


### Post #1 by @quietnurse_
> **Author:** [@quietnurse_](https://x.com/quietnurse_)  
> **Metrics:** 37 likes · 1 retweets · 10 comments · 1.3K views  


> **Source Link:** [https://x.com/quietnurse_/status/2086777296015548909](https://x.com/quietnurse_/status/2086777296015548909)  


> **Visual Context:** The image shows a stock price display for "앱셀러러 바이오로직스" (AbCellera Biologics), ticker ABCL, trading at 12,127원 ($8.54), with a premarket gain of +2,286원 (23.2%). This significant premarket surge aligns with the post celebrating $ABCL's ABCL635 Phase 2 success, reflecting positive market sentiment following the clinical trial announcement.  

> 
> "$ABCL 

ABCL635 Phase 2 Success
Congratulations"




---


## Contributing Accounts

- `@NKLinhzk` (https://x.com/NKLinhzk)